scholarly journals Platelet derived growth factor receptor alpha mediates nodal metastases in papillary thyroid cancer by driving the epithelial-mesenchymal transition

Oncotarget ◽  
2016 ◽  
Vol 7 (50) ◽  
pp. 83684-83700 ◽  
Author(s):  
Esther Ekpe-Adewuyi ◽  
Ana Lopez-Campistrous ◽  
Xiaoyun Tang ◽  
David N. Brindley ◽  
Todd P. W. McMullen
2012 ◽  
Vol 228 (2) ◽  
pp. 241-250 ◽  
Author(s):  
Jingdong Zhang ◽  
Peng Wang ◽  
Mark Dykstra ◽  
Pascale Gelebart ◽  
David Williams ◽  
...  

2018 ◽  
Vol 75 ◽  
pp. 146-153 ◽  
Author(s):  
Esther Ekpe Adewuyi ◽  
Jean Deschenes ◽  
Ana Lopez-Campistrous ◽  
Mireille M. Kattar ◽  
Sunita Ghosh ◽  
...  

Author(s):  
Wei Zhang ◽  
Ting Liu ◽  
Tianshu Li ◽  
Xudong Zhao

Abstract As important modulators in various physiological processes, circular RNAs (circRNAs) have been increasingly demonstrated in tumors, including papillary thyroid cancer (PTC). Hsa_circRNA_102002 (circ_102002) is a circRNA derived from alternative splicing of ubiquitin-specific peptidase 22 (USP22) transcript, the role of which needs further investigation. Our results suggested the upregulation of circ_102002 in PTC tissues and cells, and its promoting effects on epithelial–mesenchymal transition (EMT) and cell migration. Mechanism studies showed that circ_102002 could sponge microRNA-488-3p (miR-488-3p) and downregulate its expression. The target relationship between miR-488-3p and hyaluronic acid synthetase 2 (HAS2) in PTC was systematically studied. In addition, our results showed that HAS2 overexpression could restore the inhibited cell EMT and migration. Moreover, the inhibitory effect of downregulation of circ_102002 on PTC growth was evaluated in a mouse xenograft model, which involved miR-488-3p and HAS2 regulation. These findings about the signal axis of circ_102002/miR-488-3p/HAS2 may further elucidate the PTC pathogenesis and improve clinical treatment.


Sign in / Sign up

Export Citation Format

Share Document